KR102246097B9 - 알파-리포익산(alpha-lipoic acid)을 유효성분으로 함유하는 시스플라틴에 의한 이독성 난청 치료용 약학적 조성물 - Google Patents
알파-리포익산(alpha-lipoic acid)을 유효성분으로 함유하는 시스플라틴에 의한 이독성 난청 치료용 약학적 조성물Info
- Publication number
- KR102246097B9 KR102246097B9 KR1020190042439A KR20190042439A KR102246097B9 KR 102246097 B9 KR102246097 B9 KR 102246097B9 KR 1020190042439 A KR1020190042439 A KR 1020190042439A KR 20190042439 A KR20190042439 A KR 20190042439A KR 102246097 B9 KR102246097 B9 KR 102246097B9
- Authority
- KR
- South Korea
- Prior art keywords
- alpha
- lipoic acid
- cisplatin
- pharmaceutical composition
- hearing loss
- Prior art date
Links
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 title 2
- 229960002663 thioctic acid Drugs 0.000 title 2
- 206010011878 Deafness Diseases 0.000 title 1
- 206010033109 Ototoxicity Diseases 0.000 title 1
- 230000002730 additional effect Effects 0.000 title 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 title 1
- 229960004316 cisplatin Drugs 0.000 title 1
- 231100000888 hearing loss Toxicity 0.000 title 1
- 230000010370 hearing loss Effects 0.000 title 1
- 208000016354 hearing loss disease Diseases 0.000 title 1
- 235000019136 lipoic acid Nutrition 0.000 title 1
- 231100000262 ototoxicity Toxicity 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/026—Alpha lipoic acid, thioctic acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190042439A KR102246097B1 (ko) | 2019-04-11 | 2019-04-11 | 알파-리포익산(alpha-lipoic acid)을 유효성분으로 함유하는 시스플라틴에 의한 이독성 난청 치료용 약학적 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190042439A KR102246097B1 (ko) | 2019-04-11 | 2019-04-11 | 알파-리포익산(alpha-lipoic acid)을 유효성분으로 함유하는 시스플라틴에 의한 이독성 난청 치료용 약학적 조성물 |
Publications (3)
Publication Number | Publication Date |
---|---|
KR20200120057A KR20200120057A (ko) | 2020-10-21 |
KR102246097B1 KR102246097B1 (ko) | 2021-04-29 |
KR102246097B9 true KR102246097B9 (ko) | 2022-03-15 |
Family
ID=73034891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190042439A KR102246097B1 (ko) | 2019-04-11 | 2019-04-11 | 알파-리포익산(alpha-lipoic acid)을 유효성분으로 함유하는 시스플라틴에 의한 이독성 난청 치료용 약학적 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102246097B1 (ko) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230152605A (ko) * | 2022-04-27 | 2023-11-03 | 주식회사 파이안바이오테크놀로지 | 미토콘드리아를 유효성분으로 포함하는 난청 또는 이명의 예방 또는 치료용 약학 조성물 |
CN116440274A (zh) * | 2023-03-17 | 2023-07-18 | 烟台毓璜顶医院(青岛大学附属烟台毓璜顶医院) | c-MET及其激活剂的应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101891395B1 (ko) | 2016-06-21 | 2018-08-27 | 원광대학교산학협력단 | 시스플라틴에 의한 이독성의 예방 또는 치료용 약학적 조성물 |
-
2019
- 2019-04-11 KR KR1020190042439A patent/KR102246097B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR102246097B1 (ko) | 2021-04-29 |
KR20200120057A (ko) | 2020-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3263135A4 (en) | Pharmaceutical composition for treating cancer comprising microrna as active ingredient | |
WO2015200481A8 (en) | Mnk inhibitors and methods related thereto | |
PH12016502378A1 (en) | Substituted dihydroisoquinolinone compounds | |
EP3520796A4 (en) | COMPOSITION WITH WATER-RESOLVED URSODEOXYCHOLIC ACID FOR THE PREVENTION OR TREATMENT OF INFLAMMATIVE SKIN DISEASES OR SERIOUS PRURITUS | |
EA033374B1 (ru) | Твердые фармацевтические композиции, содержащие энзалутамид, и способ лечения | |
EA201691590A1 (ru) | Бензимидазол-2-амины в качестве ингибиторов midhi | |
PH12018500653A1 (en) | Salts and solid forms of monobactam antibiotic | |
EP3060220A4 (en) | Compositions for oral administration of zoledronic acid or related compounds for treating disease | |
HK1257615A1 (zh) | 用於治療癌症、含有多酚化合物作為活性成分的藥物組合物 | |
EP3890725A4 (en) | COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES | |
EP3915583A4 (en) | COMBINED PHARMACEUTICAL COMPOSITION FOR TUMOR TREATMENT | |
EP3597208A4 (en) | PHARMACEUTICAL COMPOSITION WITH ATPIF1 FOR THE TREATMENT OF DIABETES | |
IL287523A (en) | Useful preparations for the treatment of Pompe disease | |
EP3378491A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF NASH | |
EP3378484A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CARDIAC FIBROSIS | |
KR102246097B9 (ko) | 알파-리포익산(alpha-lipoic acid)을 유효성분으로 함유하는 시스플라틴에 의한 이독성 난청 치료용 약학적 조성물 | |
EP3375443A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RESPIRATORY DISEASES | |
EP4005587A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF LEVODOPA-INDUCED DYSKINESIA OR SUPPRESSION OF THEIR PROGRESSION | |
EP3927375A4 (en) | COMPOSITIONS FOR THE TREATMENT OF DISEASES | |
EP3716966A4 (en) | ALPHA-KETOACID COMPOSITIONS FOR THE TREATMENT OF HYPOALBUMINEMIA | |
WO2015044961A3 (en) | Pharmaceutical composition comprising capecitabine and cyclophosphamide | |
EP4021410A4 (en) | OXYTOCIN COMPOSITIONS FOR TREATING TINNITUS | |
IL278964A (en) | Pharmaceutical compositions for the treatment of sphingomyelinic acid deficiency | |
EP3964215A4 (en) | PHARMACEUTICAL COMPOSITION WITH 6-DIAZO-5-OXO-L-NORLEUCINE FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES | |
EP3773641A4 (en) | TOPICAL PHARMACEUTICAL COMPOSITIONS FOR TREATING SKIN CONDITIONS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AMND | Amendment | ||
E601 | Decision to refuse application | ||
X091 | Application refused [patent] | ||
AMND | Amendment | ||
E90F | Notification of reason for final refusal | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
G170 | Re-publication after modification of scope of protection [patent] |